Medidata Revolutionizes Clinical Trials: Efficiency through Data Interoperability and AI

Details

Medidata leverages its expertise and cutting-edge digital platforms to support over 34,000 trials and 10 million patients globally. The AI-driven 'Clinical Data Studio' accelerates data review and reconciliation by up to 80%, while risk-based quality management tools reduce patient profile review times by 50%, ensuring streamlined operations without compromising safety. A key achievement is the 'Health Record Connect,' which sets a new standard in interoperability by securely bridging healthcare data and clinical research. By integrating EHR data from various organizations with industry standards like FHIR, this solution enables seamless data exchange, significantly improving collaboration and visibility throughout the trial process. With 25 years of experience, Medidata is trusted by major pharmaceutical companies and CROs, serving as a cornerstone for accelerating life-saving therapies and enhancing patient-centric innovation.